Abstract
In the article the latest recommendations on the management of patients with endogenous subclinical hyperthyroidism are discussed. The newest classification of subclinical hyperthyroidism, based on the levels of thyrotropin, is reviewed. Treatment tactics for this group of patients is inspected. The risk factors in non-treated patients are commented.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
